(B) In the absence of Ank2-L, Ank2-XL levels are severely reduced at NMJs and aberrant MT accumulations can be observed at central boutons (highlighted in C1). At distal synaptic boutons Ank2-XL and MTs are absent (highlighted in C2). Please note that Ank2-XL levels were severely reduced also at NMJ areas directly proximal to the aberrant MT aggregates.
Scale bars represent 10 (in A) and 5 µm (in C1).
B control D C (A-B) Analysis of Ank2-XL and Futsch/MAP1B distribution.
(A) In control animals Ank2-XL (green) is present throughout the nerve terminal and partially co-localizes with Futsch/MAP1B (red). The neuronal membrane is marked by HRP (blue).
(B) In the absence of Futsch/MAP1B, the distribution of Ank2-XL remains unchanged.
(C) In the axonal compartment Ank2-XL (green) is present at the neuronal membrane (blue, HRP) but also surrounds and intermingles with Futsch/MAP1B (red) (type Ib axon innervating muscle 4).
(D) At NMJs structured illumination imaging (SIM) shows that Ank2-XL (green) surrounds and intermingles the core Futsch/MAP1B filament (red) at interbouton regions (asterisk).
Within synaptic boutons Ank2-XL is less organized but still partially co-localizes with
Futsch/MAP1B present in loop-like structures (arrowhead).
(E-G) Analysis of MT and NMJ organization at the second instar larval stage.
(E) In control animals, MTs (green) extend throughout the presynaptic terminal (arrows). (I) Lysates of S2 cells co-expressing 5 GFP-tagged Ank2-XL repeats (GFP-5xR) and 10
Futsch repeats (FR) were subjected to immunoprecipitation using GFP-Trap® beads.
Following Western blotting, we could not detect any Futsch protein in the immunoprecipitates (right). An anti-GFP antibody was used to control input levels of the GFP-tagged proteins before and after precipitation (left).
(J) Similar, we could not detect any Ank2-XL repeat protein (5xR) after precipitating a coexpresseed GFP-tagged Futsch repeat protein (GFP-FR) (right). Again, an anti-GFP antibody was used to control for input and enrichment of GFP-tagged Futsch repeats (left). 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Fly genetics
The 
Cloning and Recombineering
All constructs and recombineering events were verified by sequencing (FMI/Novartis sequencing facility).
GFP-Ank2-XL_Ct
Specific primers (Ank2-XL-Ct-f + Ank2-XL-Ct-r) were used to amplify the Ank2-XL Cterminal region from the genomic clone BACR03I22 (BACPAC Resources). To generate a pUASTattB-10xUAS destination vector carrying a N-terminal EGFP cassette suited for in vitro gateway cloning and in vivo phiC31-based integration a previously described strategy was used (Enneking et al., 2013) . A pENTR vector containing the Ank2-XL C-terminal region was generated via TOPO cloning and subsequently used to generate the final pUAST-EGFP-Ank2-XL_Ct according to standard protocols (Invitrogen).
6xHis-Ank2-XL C1
To generate the Ank2-XL C1 construct we amplified a DNA fragment from the genomic clone BACR03I22 coding for 302 aa (aa 10702-11005; primers Ank2-XL-Ct-f + Ank2-XLCt-r) directly downstream of the central Ank2-XL repeat domain. The resulting fragment was cloned into the pENTR vector via TOPO cloning and subsequently transferred into the destination vector pDEST17 using standard gateway protocols (Invitrogen) to express, purify and analyze the 6xHis-tagged Ank2-XL C1 protein in vitro.
6xHis-Ank2-XL 5xR
Similar to 6xHis-Ank2-XL C1, a synthesized cassette of 5 repeat units (5xR, see below) was sub-cloned into the pENTR vector and inserted into the pDEST17 destination vector using standard gateway protocols (Invitrogen) to allow for expression and purification of a 6xHis-Ank2-XL 5xR protein.
UAS-GFP-5xR, UAS-5xR, UAS-GFP-FR and UAS-FR expression constructs for cell culture
The pENTR vector containing the cassette of 5 repeat units was used to generate an untagged (UAS-5xR) and a N-terminal GFP-tagged (UAS-GFP-5xR) expression construct using pUASTattB-10xUAS destination vectors and gateway technology (Invitrogen). A cassette containing 10 Futsch repeats (termed FR) was amplified via PCR from the genomic clone CH321-65D05 (P[acman] Resources) using specific primers (Futsch-10xFR-f + Futsch10xFR-r) and cloned into the pENTR via TOPO cloning (Invitrogen). Following verification by sequencing the Futsch repeat cassette was transferred into a pUASTattB-10xUAS and a pUASTattB-10xUAS-EGFP destination vector (gateway cloning, Invitrogen) to generate UAS-FR and UAS-GFP-FR expression plasmids.
P[acman]-ank2-XL wt
The ank2 locus including up-and downstream sequences from the genomic clone (Venken et al., 2009; Venken et al., 2006) .
P[acman]-ank2-XL deletion constructs
To generate specific Ank2-XL variants, we used a 2-step galK mediated recombineering protocol according to Warming et al. (2005) and instructions available at the website of the National Laboratory for Cancer Research (Frederick, USA) (http://ncifrederick.cancer.gov/research/brb/recombineeringInformation.aspx). We inserted a galK selection cassette into the 3´end of the Ank2-XL specific exon (corresponding to aa 11624; primers Ank2-XL-gK-f + Ank2-XL-gK-r). Using this construct, we generated an Ank2-XL deletion construct lacking all Ank2-XL-specific sequences by fusing aa 2401 to aa construct was used to generate ΔR+ΔC construct by fusing aa 3538 to aa 11630 (primers Ank2-∆RC-f + Ank2-∆RC-r) and to generate the ΔC construct by fusing aa 10722 to aa 11629 (primers Ank2-∆C-f + Ank2-∆C-r). Furthermore, to generate a specific deletion of the central repeat domain, we deleted aa 3086 to aa 10705 by inserting a galK cassette (primers to generate galK with the required homology arms: Ank2-XL-∆R-gK-f + Ank2-XL-∆R-gK-r).
Subsequent removal of the galK cassette resulted in the fusion of aa 3085 to aa 10706
(primers Ank2-XL-∆R-f + Ank2-XL-∆R-r).
Alteration of the length of the central repeat domain
To manipulate the length of the central repeat region, a cassette containing 5 repeat units was synthesized (corresponding to repeats 3-7, renamed 5xR; GeneArt, Switzerland) with flanking 
Transgenesis
To generate transgenic flies we used the phiC31-integration system to equalize genetic backgrounds and expression levels (Bischof et al., 2007) . pUAST-and P[acman]-based constructs were integrated into the attP40 landing site (Markstein et al., 2008) . The wild-type ank2 P[acman] construct was additionally integrated into the VK37 landing site (Venken et al., 2006) . All phenotypic features associated with the loss of ank2 could be rescued by a wildtype ank2 P[acman] construct integrated in attP40 or VK37. To prepare DNA for injection final P[acman] constructs were transferred to E. coli EPI300 cells and induced for high-copy amplification as previously described (Venken et al., 2009; Venken et al., 2006) . DNA prepared using the NucleoBond BAC 100 kit (Machery-Nagel) following manufacturer's instructions was resuspended in a 10 mM Tris (pH 8.0) buffer. DNA integrity was controlled by analyzing DNA fingerprints generated using several restriction enzymes. DNA was diluted in 10 mM Tris (pH 8.0) to a final concentration of about 80-90 ng/µl before injection.
pUAST-based plasmids were injected at a concentration of 150-200 ng/µl.
Immunohistochemistry
First, second and third instar wandering larvae were dissected in ice-cold standard dissecting saline (HL3) at room temperature and fixed for 3 min in Bouin´s fixative (Sigma-Aldrich).
Mutant first and second instar larvae were identified by the absence of a GFP-marked balancer chromosome. The following primary antibodies were incubated at 4°C overnight: Prolong Gold (Invitrogen) and imaged at room temperature. As the anti-Ank2-XL antibody was generated against Ank2-XL repeat sequences (Koch et al., 2008) , the Ank2-XL protein containing 20 repeats (4 x 5xR) could be monitored in vivo whereas the Ank2-XL protein with 5 repeats was not efficiently recognized in vivo.
In-vitro MT binding assays
Upon induction 6xHis-tagged Ank2-XL Ct and Ank2-XL 5xR were expressed at 37°C in E.
coli BL21 cells and subsequently purified under native conditions using Ni-NTA spin columns according to manufacturer's instructions (Qiagen) and dialyzed. MT binding assays were performed using the MT binding protein spin-down assay kit (Cytoskeleton). In vitro polymerized and taxol-stabilized MTs were incubated with approximately 10 µg of purified protein at 25°C for 30 min, loaded onto a 60% glycerol gradient, and centrifuged for 10 min at 60'000 g in an Optima tabletop ultracentrifuge (Beckmann Coulter) at 25°C. After centrifugation, supernatant and pellet fractions were separated and analyzed using Coomassie staining of NuPAGE gels (Invitrogen). For the MT co-precipitation assay purified 6xHis-tagged proteins were coupled to Ni-NTA magnetic beads according to the manufacturer's guidelines (Qiagen) and incubated with in vitro polymerized, taxol-stabilized MTs for 1 h at room temperature on a rolling device. Precipitation of magnetic Ni-NTA beads was performed according to manufacturer's instructions (Qiagen). Samples were separated on NuPAGE gels (Invitrogen) and proteins were transferred to PVDF membranes according to standard protocols. Primary antibodies were incubated overnight at 4°C [mouse anti-β-tubulin E7, 1:500; rabbit anti-His, 1:1000 (clone H-15, Santa Cruz)]. HRP-conjugated anti-mouse and anti-rabbit were used at 1:10 000 at room temperature for 1h. PVDF-membranes were incubated with ECL substrate (SuperSignal West Pico kit, Thermo Scientific) and developed on film (Fujifilm).
Cell culture, cell transfection and immunoprecipitation from S2 cells
Drosophila S2 cells were propagated in 1x Schneider's Drosophila media at 25°C
supplemented with 10% FBS, 50 U/ml penicillin and 50 µg/ml streptomycin. Cells were cotransfected in 12 well plates (10 6 ) with act5C-Gal4 DNA and pUAST constructs using Fugene according to manufacturer´s instructions (Roche) as described previously (Stephan et al., 2008) . Following lysis with ice-cold lysis buffer with protease inhibitor cocktail (Roche), cell lysates were centrifuged for 10 min at 10,000g to yield the cytoplasmic supernatant. The cytoplasmic supernatant was subjected to immunoprecipitation using GFP-trap® beads according to manufacturer´s instructions (Chromotek). Samples were separated on NuPAGE gels (Invitrogen) and proteins were transferred to PVDF membranes according to standard protocols. The following primary antibodies were incubated overnight at 4°C: mouse anti-GFP (1:750; clone 7.1/13.1, Roche), rabbit anti-Ank2-XL (1:8000), mouse anti-Futsch
(1:2000).
Immunoprecipitation from larval brains
For immunoprecipitation (IP) 60 larval brains from control animals were collected, grinded in ice-cold NP40-based lysis buffer and incubated on ice for additional 30 min similar to Enneking at al. (2013) . After centrifugation at 4°C at 13 000 rpm for 10 min the supernatant was equally spilt between control IPs using empty protein-G beads (Dynabeads, Life
Technologies) and protein-G beads pre-incubated with anti-Ank2-XL using manufacturer's guidelines and incubated at room temperature on a rolling device for 1 h. Similarly, larval 
Phenotypic Analysis and Quantification at the light level
Statistical analysis was performed using Microsoft Excel and StatPlus (AnalystSoft Inc.). P < 0,05 was accepted as statistically significant (*P < 0,05, ** P < 0,01, and *** P < 0,001). In all bar graphs data are presented as mean values ± SEM. In box plots the central mark represents the median, the edges of the boxes the 25 th and 75 th percentiles and whiskers minimum to maximum.
Aberrant organization of the MT cytoskeleton
Futsch and MT organization were scored as aberrant when synaptic terminals contained either aggregations or irregular core filaments. Futsch staining was used to quantify for alterations in distal MT cytoskeleton organization as this allowed unambiguous distinction between the neuronal and muscle MT cytoskeleton. The synaptic vesicle marker DvGlut and HRP were used to identify terminal boutons. All phenotypes were quantified on muscle 4 NMJs in segments A2-A6 and are presented as percentage of affected NMJs per animal.
Axonal MT accumulations
Axonal MT accumulations were scored as aberrant when axons innervating muscle 4 NMJs exhibit abnormal aggregations at the exit point from the peripheral nerve. Accumulations were quantified at muscle 4 axons in segments A2-A6 of the indicated genotypes and data are presented as percentage of affected muscle 4 axons per animal.
Relative area and maximum diameter of Futsch/MT core filaments at synaptic terminals
The relative area and maximum diameter of Futsch/MT core filaments were determined in calibrated confocal images taken from muscle 4 NMJs in segment A3 using the Imaging Tablet 
Synaptic instability
Synaptic retractions were quantified using presynaptic Brp and postsynaptic DGluRIII. Synaptic retractions were quantified in segments A2-A6 for the indicated muscle groups.
Area of individual synaptic boutons
Synaptic bouton area was determined using Synapsin-HRP staining on muscle 4 NMJs in segment A3 using the Imaging Tablet module in IMS client (Imagic). Data are presented as mean percentage of boutons per NMJ +/-SEM, except for histograms where distributions of bouton area categories over all synaptic boutons are presented.
Relative immunofluorescence of Ank2-XL and Futsch/MAP1B in synaptic terminals
To analyze Ank2-XL and Futsch levels in synaptic terminals and in peripheral nerves, confocal stacks were acquired of muscle 4 NMJs in segment A3 from the indicated genotypes using identical imaging parameters. Relative fluorescence intensities were determined in FIJI/ImageJ using a custom-made macro (details available on request). Fluorescence intensities in control and mutant animals were determined at the distal bouton (entire bouton), at a central area of the terminal (over a distance of 10 µm), and at the peripheral nerve prior to the muscle 4 branch point (35 µm 2 area). Control intensities were set to 100 % and values are presented as mean values +/-SEM per NMJ relative to the control.
Relative immunofluorescence of Brp and DvGlut in peripheral nerves
To determine Brp and DvGlut levels in axons, confocal stacks of peripheral nerves were acquired from the indicated genotypes using identical imaging conditions. The relative fluorescence intensity was determined in FIJI/ImageJ using a custom-made macro (details 
Electron Microscopy and Ultrastructural Analysis
Third instar wandering larvae were dissected in ice-cold physiological saline that was then exchanged with 2% glutaraldehyde in 0.12 M Na-cacodylate buffer at pH 7.4 according to Pielage et al. (2011) . The dissected larvae were fixed in place for 10 min, then transferred to vials containing fresh fixative and fixed for a total of 1 h. Larvae were rinsed with 0.12 M Nacacodylate buffer and postfixed with 1% osmium tetroxide in 0.12 M Na-cacodylate for 1 h.
After postfixation, specimens were rinsed with 0.12 M Na-cacodylate followed by water and then stained with 1% aqueous uranyl acetate for 1 h en bloc to enhance contrast. After dehydration with ethanol, larvae were passed through propylene oxide and embedded in Embed812 resin (EMS). Blocks were trimmed at the level of the muscle of interest and ultrathin sections (30-50 nm) cut with a Leica Ultracut EM UC7 were collected on Formvar coated copper slot grids and stained with uranyl acetate and Reynold's lead. Images were acquired at 80 kV on a CM10 (FEI, Endhoven) equipped with a side-mounted digital camera (Veleta, Olympus). Images were processed for manual tracing in Neurolucida (Microbrightfield).
Briefly, after calibration the contour mode was selected and contours of the axons profile were drawn manually. Markers were then added to the center of the microtubules.
Microtubules were identified in consecutive serial sections. Files were saved in .ASC containing the coordinates of all traced contours and markers. To analyze images, a file parser was written in Matlab to read the neurolucida files (.ASC) in which the coordinates of microtubules centroids and axon contour points were stored. The axon contour points were sub-sampled using cubic spline interpolation. The axon area was then calculated from the polygon defined by the ordered list of sub-sampled contour points. A square matrix having as many rows as marked microtubules was used to store the calculated centroid-to-centroid distances. Each row vector of the matrix corresponded to one particular microtubule and recorded the distances to all the other microtubules present in the axon. After sorting distances in ascending order, means and standard deviations among the k nearest neighbors were calculated, k varying between 1 and 6. By gathering this information about images of similar axon types, distance vectors were generated and used for statistics. The Wilcoxon rank sum test was used to determine statistical significance for MT distance between genotypes and the one-way ANOVA test was used to determine statistical significance for MT number per axon.
Live imaging of axonal transport
Third instar wandering control or futsch; ank2-XL ∆ mutant larvae expressing mitoGFP or sytGFP using 5053A-Gal4 were dissected in HL3 saline supplemented with 100 mM 1-naphthylacetyl-spermin-trihydrochloride (NSH; Sigma-Aldrich) to block postsynaptic glutamate receptor activation and to prevent muscle contraction. Larvae were prepared for live imaging on a custom-made microscope slide in a chamber filled with Sylgard.
Mitochondria and vesicle movements in peripheral nerves were imaged 5-8 min after dissection at the position of the segment A4. 5053A positive axons of the nerve innervating segment A5 were selected for imaging. Larvae were recorded on an upright spinning disk system (Olympus, 40x objective) equipped with an EM-CCD camera (Photometrics).
Individual confocal stacks were acquired for 300-420 s at a time interval of 3 s. Kymographs were generated and analyzed in FIJI/ImageJ for at least 180 s using a kymograph plugin (open source, written by J. Rietdorf and A. Seitz). Raw data were processed and analyzed using Microsoft Excel and StatPlus (AnalystSoft Inc.). Movies were generated from original confocal stacks/image series using FIJI/ImageJ.
Electrophysiology
Electrophysiological recordings were performed at room temperature in HL3 saline on muscle 6 in segment A2 or A3 using sharp microelectrodes (12-16 MΩ) according to Frank et al. were recruited. Quantal content was determined for each recording by calculating the ratio of average EPSP and average mEPSP. Quantal contents were calculated for each recording and then averaged across all NMJs of the indicated genotypes. Philanthotoxin-433 (PhTx, SigmaAldrich) treatment was performed as described in Frank et al. (2006) . Briefly, pinning the anterior and posterior extremities of third instar wandering larvae followed by a dorsal incision produced a semi-intact preparation. PhTx at a final concentration of 4 µM was perfused into the larvae through the dorsal incision and the animal was incubated in this PhTx bath application for 10 min. After washout of PhTx, dissection was completed and electrophysiological recordings were performed
